Researchers have developed an innovative drug screening platform designed to identify compounds that precisely target the primary cause of numerous…
Read More
UC Davis Study Identifies Distinct Brain Chemical Signature in Patients with Anxiety Disorders
A groundbreaking meta-analysis led by researchers at UC Davis Health has identified a measurable chemical shift in the brains of…
Read More
UC Davis Health Study Reveals Significant Choline Deficiencies in the Brains of Individuals with Anxiety Disorders
A groundbreaking meta-analysis led by researchers at UC Davis Health has identified a consistent chemical signature in the brains of…
Read More
First Blueprint of Human Skeletal Development Reveals Origins of Arthritis and Bone Growth Disorders
In a landmark achievement for regenerative medicine and developmental biology, an international team of scientists has unveiled the first comprehensive…
Read More
Molecular Gateway to Relief How TRPV4 Functions as the Biological Off Switch for Scratching Behavior in Chronic Itch Disorders
Scientists have identified a critical biological "off-switch" for scratching behavior, a discovery that could revolutionize the treatment of chronic itch…
Read More
Astrocytes and the Neuroscience of Fear: How Star-Shaped Cells Regulate Memory and Anxiety Disorders
For decades, the prevailing narrative in neuroscience centered almost exclusively on the neuron as the primary architect of human thought,…
Read More
Deciphering the Inflammatory Niche: How Bone Marrow Microenvironments Drive the Progression of Pre-Leukemic States and Age-Related Blood Disorders
Every second, the human bone marrow performs a biological feat of staggering proportions, generating millions of fresh blood and immune…
Read More
OrsoBio’s LXR Inverse Agonist Shows Promise for Hard-to-Treat Triglyceride Disorders, Paving New Path Beyond GLP-1 Dominance
OrsoBio, a specialized biotechnology firm dedicated to pioneering therapies for obesity and its associated metabolic conditions, is strategically charting a…
Read More
Early Life Stress Linked to Long-Term Gastrointestinal Disorders Through Brain-Gut Communication Pathways
A comprehensive multi-institutional study published in the journal Gastroenterology has established a profound link between early life adversity and the…
Read More
OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disorders
OrsoBio, a specialized biotechnology company strategically focused on addressing obesity and its myriad related metabolic dysfunctions, is charting a course…
Read More
